Literature DB >> 22659531

A prothrombotic state is associated with early arterial damage in hypertensive patients.

Cristiana Catena1, GianLuca Colussi, Gabriele Brosolo, Leonardo A Sechi.   

Abstract

AIM: A prothrombotic state is associated with organ damage in hypertensive patients. Carotid intima-media thickness (IMT) is an early marker of vascular damage that anticipates the development of atherosclerotic plaques. The aim of the present study was to investigate the relationships between subclinical carotid damage and markers of the prothrombotic state in hypertension.
METHODS: In 258 essential hypertensive patients who were consecutively recruited at a hypertension clinic an ultrasound carotid scan was performed with assessment of the IMT and plasma levels of C-reactive protein, fibrinogen, fibrin D-dimer, prothrombin fragment 1+2, homocysteine, and lipoprotein(a) were measured.
RESULTS: Patients with an IMT above the median of the distribution (800 µm) were older and had greater BMI, pulse pressure, duration of hypertension, and prevalence of coronary heart disease than patients with an IMT below the median. Patients with higher IMT had also greater levels of C-reactive protein, fibrinogen, fibrin D-dimer, and homocysteine. Regression analysis showed a direct relationship of IMT with age, waist circumference, pulse pressure, fibrinogen, fibrin D-dimer, and number of cigarettes smoked per day, and an inverse relationship with creatinine clearance. On multivariate analysis, age, pulse pressure, and fibrin D-dimer were independently related with IMT.
CONCLUSION: In hypertensive patients, subclinical carotid damage is related with evidence of activated coagulation system suggesting a prothrombotic state. This might contribute to the development of hypertensive arterial damage even in the earliest stages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659531     DOI: 10.5551/jat.10819

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  6 in total

1.  Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk.

Authors:  Jinyang Lu; Dandan Niu; Di Zheng; Quan Zhang; Wenhua Li
Journal:  Biomed Rep       Date:  2018-10-19

2.  The Impact of Metabolic Syndrome, Homocysteine, and B Vitamins on Carotid Artery Intima-Media Thickness in Hypertensive Patients.

Authors:  Chung-Pin Liu; Yu-Li Lin; Yen-Hung Lin; Kuan-Yin Pao; Vin-Cent Wu; Ta-Chen Su; Chi-Sheng Hung; Churn-Shiouh Gau; Juey-Jen Hwang
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

Review 3.  Hypertension and patients with acute coronary syndrome: Putting blood pressure levels into perspective.

Authors:  Konstantinos Konstantinou; Costas Tsioufis; Areti Koumelli; Manos Mantzouranis; Alexandros Kasiakogias; Michalis Doumas; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-12       Impact factor: 3.738

4.  Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension.

Authors:  Cristiana Catena; Gianluca Colussi; Valentina Fagotto; Leonardo A Sechi
Journal:  J Res Med Sci       Date:  2017-05-30       Impact factor: 1.852

5.  Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study.

Authors:  GianLuca Colussi; Francesca Zuttion; Bruno Bais; Pierluigi Dolso; Mariarosaria Valente; Gian Luigi Gigli; Daniele Gasparini; Massimo Sponza; Cristiana Catena; Leonardo A Sechi; Alessandro Cavarape
Journal:  J Clin Med       Date:  2018-09-17       Impact factor: 4.241

6.  Exacerbation of Thrombotic Responses to Silver Nanoparticles in Hypertensive Mouse Model.

Authors:  Zannatul Ferdous; Sumaya Beegam; Nur E Zaaba; Ozaz Elzaki; Saeed Tariq; Yaser E Greish; Badreldin H Ali; Abderrahim Nemmar
Journal:  Oxid Med Cell Longev       Date:  2022-01-15       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.